Dr. Curtis Lisante Cetrulo Jr., MD

Dr. Cetrulo practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Cetrulo's NPI, 1801084462, was assigned on October 9, 2007. Dr. Cetrulo graduated from Tufts University School of Medicine in 1999. Dr. Cetrulo's California license number on file is A88073.

Dr. Cetrulo's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Cetrulo's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. The medical group on file is Cedars-Sinai Medical Center. Dmand AI also links Dr. Cetrulo to 4 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cetrulo practices, 2 sites in all. Vendor and product names are available with a free account.

Plastic surgery is Dr. Cetrulo's primary specialty in the NPI Registry, under taxonomy code 208200000X. Dr. Cetrulo is board certified in plastic surgery by the American Board of Plastic Surgery. Dmand AI has Dr. Cetrulo's licenses on file in 8 states: California, Massachusetts, New York, Rhode Island, Connecticut, Maine, New Hampshire and Florida.

Dmand AI lists breast reconstruction and breast surgery among the conditions Dr. Cetrulo treats.

CMS data shows 12 Medicare services from Dr. Cetrulo across 1 procedure code in 2024, for 30 Medicare patients. Medicare paid $2,161 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 30 Medicare patients who saw Dr. Cetrulo in 2024. The largest group is 65 to 74, with 14 patients. 70% of them have high blood pressure, and 63% have arthritis. 40% are also on Medicaid. Their average risk score is 2.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cetrulo's median patient age at 59, with 69% women.

Dr. Cetrulo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cetrulo as offering telehealth. CMS counts 21 procedures of melanoma (skin cancer) excision by Dr. Cetrulo, more than 75% of the clinicians it reports for that procedure.

Dmand AI links 129 papers to Dr. Cetrulo, published from 2011 to 2025. 2024 was the busiest year, with 21. The most frequent topics are Vascularized Composite Allotransplantation, Graft Rejection and Composite Tissue Allografts. Dr. Cetrulo has published most often in Plast Reconstr Surg. Dr. Cetrulo's most frequent co-authors are William Gerald Austen, MD, Jonathan Michael Winograd, MD and Amy S. Colwell, MD.

CMS Open Payments shows 78 general payments to Dr. Cetrulo from 12 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 79% of the total. TELA Bio, Inc. paid the most, $5,990.

Dmand AI lists 1 award for Dr. Cetrulo.

Dr. Cetrulo graduated from Tufts University School of Medicine in 1999. Dr. Cetrulo is a member of ACS.

Dr. Cetrulo is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.